Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2014 August;55(4) > The Journal of Cardiovascular Surgery 2014 August;55(4):461-4

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632


eTOC

 

REVIEWS  LATEST DEVELOPMENTS IN SFA MANAGEMENT


The Journal of Cardiovascular Surgery 2014 August;55(4):461-4

language: English

Prime time for drug eluting balloons in SFA interventions?

Brodmann M.

Division of Angiology, Medical University of Graz, Graz, Austria


PDF  


Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite enormous improvements in device and treatment technology the long-term patency rate and clinical benefit of endovascular treatment in the respective vascular bed is not satisfying. Drug coated balloon technology as a treatment option in femoropopliteal disease has shown encouraging results in first-in-man trials, which have now been proven in large randomized controlled trials.

top of page

Publication History

Cite this article as

Corresponding author e-mail

marianne.brodmann@medunigraz.at